D'Amario Federico, Vitale Umberto, De Dona Ferdinando, Ruosi Luca, Cofone Alessandro, Loppini Mattia
Orthopedic Unit, Humanitas San Pio X, Via Francesco Nava, 31, 20159 Milano, Italy.
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 4, Pieve Emanuele, 20072 Milano, Italy.
J Clin Med. 2025 Mar 5;14(5):1748. doi: 10.3390/jcm14051748.
Unicompartmental knee arthroplasty (UKA) is a viable treatment option for patients with isolated knee osteoarthritis. This study evaluated the clinical outcomes of the JII UK (Smith & Nephew, Memphis, TN, USA) hypoallergenic, fixed-bearing UKA implant in a medium cohort of patients undergoing both medial and lateral procedures with a short-term follow-up. : A retrospective review was conducted on 257 consecutive patients who underwent primary UKA using the JII UK implant between December 2020 and December 2022. Clinical outcomes were assessed using the Knee Society Score (KSS), Knee Society Function Score (KSFS), Oxford Knee Score (OKS), UCLA Activity Score, Forgotten Joint Score (FJS-12), and satisfaction. Survivorship analysis was performed, and complications were recorded. : At the 2-year follow-up, the implant survival rate was 99.61%. Statistical significant improvements were observed in all clinical scores, with high patient satisfaction. The mean UCLA Activity Score increased from 4.53 preoperatively to 7.3 at 24 months. : This study demonstrates promising short-term clinical outcomes for the hypoallergenic fixed-bearing medial and lateral UKA implant, with high patient satisfaction and a low complication rate. Further studies with longer follow-up periods are warranted to confirm these findings.
单髁膝关节置换术(UKA)是孤立性膝关节骨关节炎患者可行的治疗选择。本研究评估了JII UK(美国田纳西州孟菲斯市的史赛克公司)低致敏性、固定平台UKA植入物在接受内侧和外侧手术的中等规模队列患者中的临床结果,并进行了短期随访。对2020年12月至2022年12月期间连续257例行初次UKA并使用JII UK植入物的患者进行回顾性研究。使用膝关节协会评分(KSS)、膝关节协会功能评分(KSFS)、牛津膝关节评分(OKS)、加州大学洛杉矶分校活动评分、遗忘关节评分(FJS-12)以及满意度来评估临床结果。进行了生存率分析,并记录并发症。在2年随访时,植入物生存率为99.61%。所有临床评分均有统计学意义的改善,患者满意度高。加州大学洛杉矶分校活动评分的平均值从术前的4.53提高到24个月时的7.3。本研究表明,低致敏性固定平台内侧和外侧UKA植入物的短期临床结果令人满意,患者满意度高,并发症发生率低。有必要进行更长随访期的进一步研究以证实这些发现。